Can Red Light Therapy Treat Dry Eye Disease? What a Randomized Trial Found

Dry eye disease is common, often chronic, and existing treatments don't work well for everyone — which is why a randomized trial testing a non-drug light-based option is a meaningful addition to the evidence base.

What the research looked at

Published in Scientific Reports in 2022, this prospective, randomized, observer-masked trial enrolled 40 patients with dry eye disease, split evenly into a light therapy group and a placebo group. The treatment group received low-level LED light therapy twice a week for three weeks (6 sessions total). Researchers measured several standard dry eye indicators, including the Ocular Surface Disease Index (a symptom questionnaire), tear film break-up time, the Schirmer test (which measures tear production), and meibomian gland function.

What they found

The light therapy group showed a significantly greater improvement in the primary symptom score compared to the placebo group, along with measurable improvements in the secondary tear-film and ocular surface measures.

What this means in practice

This is a well-designed trial — randomized, placebo-controlled, and observer-masked (the person assessing outcomes didn't know who received which treatment) — which is a meaningfully rigorous design for an eye-care intervention. The sample size (40 patients) is modest, so larger confirmatory trials would strengthen the case further, and it used a specific in-clinic LED protocol rather than at-home devices. Still, it's a genuine positive signal from a credible journal for a common, often frustrating condition with limited treatment options.